Raising financing through strategic timing

Nature Nanotechnology 12, 93 (2017).
doi:10.1038/nnano.2017.1

Authors: Elicia Maine & V. J. Thomas
Strategic timing can be key for nano-drug-delivery ventures to get financing. Timely publications engage potential partners; early broad, blocking, relevant patents demonstrate the potential to appropriate value; and venture formation closer to clinical viability better aligns its timeline with that of venture capitalists.

Source: Nature Nanotechnology - February 6, 2017 Category: Nanotechnology Authors: Elicia Maine V. J. Thomas Tags: Commentary Source Type: research